UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007533
Receipt number R000008885
Scientific Title Explorative trial of suppression effect of preoperative enteral nutrition enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy :a double blinded and randomaized controlled trial
Date of disclosure of the study information 2012/03/30
Last modified on 2012/03/19 15:25:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Explorative trial of suppression effect of preoperative enteral nutrition
enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy
:a double blinded and randomaized controlled trial

Acronym

Explorative trial of suppression effect of preoperative enteral nutrition
enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy
:a double blinded and randomaized controlled trial

Scientific Title

Explorative trial of suppression effect of preoperative enteral nutrition
enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy
:a double blinded and randomaized controlled trial

Scientific Title:Acronym

Explorative trial of suppression effect of preoperative enteral nutrition
enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy
:a double blinded and randomaized controlled trial

Region

Japan


Condition

Condition

Patients to require pancreaticoduodenectomy

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify suppression effect of preoperative enteral nutrition
enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The serum IL-6 value before and after pancreaticoduodenectomy

Key secondary outcomes

The nutrition status after preoperative enteral nutrition enrichied with Eicosapentaenoic Acid(EPA)
The cytokine level after pancreaticoduodenectomy
CD4/CD8 T lymphocyte balance after pancreaticoduodenectomy
The incidence of post-operative infectious complications
The incidence of adverse event


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

enteral nutrition
enrichied with Eicosapentaenoic Acid(EPA)

Interventions/Control_2

enteral nutrition

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Histologically or clinically diagnosed as pancreaticoduodenal cancer (i.e. pancreas head cancer, biliary cancer, papilla cancer or duodenal cancer)
(2)Treated with curative resection
(3)Needed to be admitted for a week or more in order to relieve jaundice
(4)ECOG performance formans status is 0 or 1
(5)Fulfil all following conditions
WBC < 10,000/mm3
Hb > 8.0g/dL
Cre < 1.5mg/dl

Key exclusion criteria

(1)With poor oral intake
(2)With other nutrition therapy
(3)Being immunocompromised status or receiving steroids
(4)With uncontrolled diabetes mellitus
(5)With inflammatory bowel disease
(6)With bacterial or viral infection
(7)With radiation therapy, chemotherapy or nutrition therapy before registration
(8)With psychiatric disorder
(9)Possibly pregnant

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Katsuhiko Uesaka

Organization

Shizuoka Cancer Center

Division name

Division of Hepato-Biliary-Pancreatic Surgery

Zip code


Address

1007 Shimonagakubo Nagaizumityou Suntougun Shizuoka Japan

TEL

0559895222

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shuichi Aoki

Organization

Shizuoka Cancer Center

Division name

Division of Hepato-Biliary-Pancreatic Surgery

Zip code


Address

1007 Shimonagakubo Nagaizumityou Suntougun Shizuoka Japan

TEL

0559895222

Homepage URL


Email

shuichi1124@msn.com


Sponsor or person

Institute

Shizuoka Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Pharma Valley Center

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡がんセンター(静岡県)


Other administrative information

Date of disclosure of the study information

2012 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 03 Month 05 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 03 Month 19 Day

Last modified on

2012 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008885


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name